Related Experiment Video
Updated: Aug 8, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases
Yuexing Zhang1, Nicholas Woodford, Xianmin Xia
1Greenebaum Cancer Center, University of Maryland, Baltimore, MD 21201, USA.
Abstract:
Ebp1, an ErbB3 binding protein that is a member of the proliferation-associated PA2G4 family, inhibits the proliferation and induces the differentiation of human ErbB positive breast and prostate cancer cell lines. Ebp1 binds the tumor suppressor retinoblastoma protein (Rb) both in vivo and in vitro, and Rb and Ebp1 cooperate to inhibit the transcription of the E2F1-regulated cyclin E promoter. We show here that Ebp1 can inhibit the transcription of other E2F-regulated reporter genes and of several endogenous E2F-regulated genes important in cell cycle progression in both Rb positive and Rb null cells. The Ebp1-mediated transcriptional repression depended on the presence of an E2F1 consensus element in the promoters. A fusion of Ebp1 with the GAL4 DNA binding domain protein had independent transcriptional repression activity that mapped to the C-terminal region of Ebp1. This C-terminal region of Ebp1 bound functional histone deacetylase (HDAC) activity and inhibitors of HDAC significantly reduced Ebp1-mediated repression. Ebp1 bound HDAC2, but not HDAC1, in vitro. An Ebp1 mutant lacking the HDAC binding domain failed to inhibit transcription. Our results suggest that Ebp1 can repress transcription of some E2F-regulated promoters and that one mechanism of Ebp1- mediated transcriptional repression is via its ability to recruit HDAC activity.
Insights
ErbB3 binding protein 1 (Ebp1) inhibits cancer cell proliferation by repressing E2F target genes. This repression involves recruiting histone deacetylase (HDAC) activity to specific DNA elements.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Cycle Regulation
Background:
- ErbB3 binding protein 1 (Ebp1) is a proliferation-associated protein.
- Ebp1 inhibits proliferation and induces differentiation in ErbB-positive breast and prostate cancer cells.
- Ebp1 interacts with the retinoblastoma protein (Rb) to inhibit E2F1-regulated gene transcription.
Purpose of the Study:
- To investigate the broader transcriptional regulatory role of Ebp1.
- To elucidate the mechanism underlying Ebp1-mediated transcriptional repression.
- To determine if Ebp1's repression activity is dependent on histone deacetylase (HDAC) recruitment.
Main Methods:
- Ebp1's effect on various E2F-regulated reporter genes and endogenous genes was assessed.
- Experiments were conducted in both Rb-positive and Rb-null cell lines.
- GAL4-Ebp1 fusion protein assays and in vitro binding assays with HDACs were performed.
Main Results:
- Ebp1 repressed transcription of multiple E2F-regulated genes, independent of Rb status.
- Transcriptional repression was dependent on an E2F1 consensus element.
- Ebp1's C-terminal region bound HDAC activity, and HDAC inhibitors reduced repression.
Conclusions:
- Ebp1 functions as a transcriptional repressor of E2F-regulated promoters.
- Ebp1 recruits HDAC activity to mediate transcriptional repression.
- This mechanism highlights a novel role for Ebp1 in cell cycle control and cancer.
Related Concept Videos
RNA Polymerase II Accessory Proteins
Cell Specific Gene Expression
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators
Co-activators and Co-repressors

